Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosis

Tingli Guo(Xi'an Jiaotong University)
Molecular Medicine
September 28, 2023
Cited by 75


Related Papers

No related papers found

Powered by citation graph analysis